ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,216Medicare Part D Prescriptions Filled, Including Refills

Rank: 40 out of 1121

$1.38M Total Retail Price of All Prescriptions

Rank: 25 out of 1121

728 Patients Receiving at Least One Drug in Part D
57%Patients 65 Years and Older
79% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 728 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

23% of this provider’s 728 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 13,101 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
LISINOPRIL 906 551 1 4
HYDROCODONE-ACETAMINOPHEN 749 519 S3 2 3
SIMVASTATIN 674 365 3 1
FUROSEMIDE 605 460 4 7
OMEPRAZOLE 600 306 5 6
LEVOTHYROXINE SODIUM 581 407 6 2
WARFARIN SODIUM 472 368 7 11
SUBOXONE 414 0 8 184
TRAMADOL HCL 383 187 9 25
CITALOPRAM HBR 352 209 10 18
METFORMIN HCL 337 159 11 8
AMLODIPINE BESYLATE 324 256 12 5
POTASSIUM CHLORIDE 317 214 13 12
GABAPENTIN 301 120 14 13
HYDROCHLOROTHIAZIDE 299 169 15 10
SERTRALINE HCL 298 248 16 21
RANITIDINE HCL 289 103 17 33
ZOLPIDEM TARTRATE 277 132 18 19
CARVEDILOL 254 193 19 20
GLIMEPIRIDE 223 115 20 34
METOPROLOL TARTRATE 219 125 21 9
SPIRIVA 215 111 22 49
ATENOLOL 192 114 23 16
NEXIUM 188 57 24 24
LANTUS 181 86 25 52
BENAZEPRIL HCL 180 116 26 41
CLOPIDOGREL 178 141 27 27
ALENDRONATE SODIUM 177 143 28 37
PANTOPRAZOLE SODIUM 164 127 29 29
LOVASTATIN 162 49 30 26
PROAIR HFA 161 75 31 48
VENLAFAXINE HCL ER 158 38 32 113
MIRTAZAPINE 156 61 33 56
PLAVIX 152 117 34 42
TAMSULOSIN HCL 148 115 35 32
POLYETHYLENE GLYCOL 3350 142 43 36 70
DIGOXIN 141 117 37 59
ATORVASTATIN CALCIUM 138 113 38 15
BUSPIRONE HCL 135 108 39 114
SINGULAIR 135 57 39 78
NYSTATIN 125 104 41 147
NOVOLOG 124 83 42 139
GEMFIBROZIL 119 40 43 88
FLUOXETINE HCL 117 39 44 60
CYCLOBENZAPRINE HCL 117 50 R 44 83
QUETIAPINE FUMARATE 113 65 46 75
NAMENDA 111 111 47 53
IBUPROFEN 101 26 48 110
ROPINIROLE HCL 100 48 49 91
RISPERIDONE 95 70 50 82
MONTELUKAST SODIUM 95 37 50 144
DILTIAZEM 24HR CD 94 81 52 99
DONEPEZIL HCL 94 94 52 35
KLOR-CON M20 93 55 54 85
ESCITALOPRAM OXALATE 92 50 55 94
MELOXICAM 90 75 56 22
PROMETHAZINE HCL 90 47 R 56 67
PAROXETINE HCL 89 43 58 58
TIZANIDINE HCL 89 15 58 124
BUPROPION HCL SR 87 36 60 205
LYRICA 87 33 60 76
FLUTICASONE PROPIONATE 86 30 62 36
NABUMETONE 85 52 63 145
LISINOPRIL-HYDROCHLOROTHIAZIDE 83 42 64 31
TRAZODONE HCL 83 29 64 40
FENOFIBRATE 83 50 64 71
LANTUS SOLOSTAR 82 45 67 109
BENAZEPRIL-HYDROCHLOROTHIAZIDE 82 50 67 153
CYMBALTA 82 49 67 50
AMITRIPTYLINE HCL 81 69 R 70 61
ADVAIR DISKUS 81 44 70 64
INSULIN SYRINGE 80 28 72 77
SPIRONOLACTONE 78 71 73 54
ALBUTEROL SULFATE 77 55 74 141
PREDNISONE 75 70 75 43
PRAVASTATIN SODIUM 75 38 75 14
NORTRIPTYLINE HCL 74 51 77 215
FENTANYL 73 51 S2 78 100
GLYBURIDE 72 27 R 79 51
ESTRADIOL 72 30 R 79 95
TRICOR 72 35 79 126
CLONIDINE HCL 72 54 79 39
DOXYCYCLINE HYCLATE 72 56 79 103
DIOVAN 69 53 84 45
BACLOFEN 69 19 84 131
CRESTOR 69 49 84 28
DIVALPROEX SODIUM 68 55 87 98
OXYCODONE HCL-ACETAMINOPHEN 67 44 S2 88 86
FAMOTIDINE 67 23 88 63
LANSOPRAZOLE 66 36 90 162
DICYCLOMINE HCL 65 44 91 206
GLIPIZIDE 63 60 92 84
VENTOLIN HFA 62 33 93 92
TRAVATAN Z 62 42 93 319
EXELON 62 62 93 119
LEVEMIR 61 34 96 157
SEROQUEL 61 24 96 134
OXAPROZIN 60 0 98 353
ACTOS 60 28 98 133
DOXAZOSIN MESYLATE 60 40 98 93
BYETTA 59 41 101 328
HYDROXYZINE HCL 56 29 R 102 168
MORPHINE SULFATE ER 56 18 S2 102 87
AMLODIPINE BESYLATE-BENAZEPRIL 56 46 102 65
MUPIROCIN 55 50 105 225
METOCLOPRAMIDE HCL 55 13 105 120
OXYBUTYNIN CHLORIDE ER 55 55 105 182
COMBIVENT 54 17 108 129
MECLIZINE HCL 54 32 108 115
NYSTOP 53 40 110 290
INDOMETHACIN 53 30 R 110 287
LOSARTAN POTASSIUM 53 36 110 17
JANUVIA 51 20 113 81
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 11, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.